S

Active Director Director DIN 08292916
DIN 08292916 First appointment Dec 2018 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2018
Shareholding value •••• Premium profile

About Sandeep

Data last updated:

Sandeep is a Director at Cazimehak Pharma Private Limited (since 2018). The company operates in Food And Beverages. Cazimehak Pharma Private Limited reported revenue of ₹4.2 Lakh (FY 2024).

DIN 08292916
Primary Designation Director
Industry Food And Beverages
First Appointment 06 Dec 2018
Oldest Company Age 7 yrs
Largest company Cazimehak Pharma Private Limited · ₹4.2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cazimehak Pharma Private Limited U24304HR2018PTC077221
Director06 Dec 20182018₹4.2 Lakh (FY 2024)Active

Board colleagues of Sandeep

NameDINCompanyDesignation
Sanjay08292922Cazimehak Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cazimehak Pharma Private Limited
Premium access

Shareholding and investment profile for Sandeep

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sandeep

Sandeep currently holds 1 directorship: Cazimehak Pharma Private Limited (Director, since 06 Dec 2018, revenue ₹4.2 Lakh (FY 2024)).

Sandeep was first appointed on 06 Dec 2018 as Director at Cazimehak Pharma Private Limited.

The current boards of Sandeep's companies include Sanjay (Cazimehak Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available